ArticleMethods in molecular biology (Clifton, N.J.)2025
Bioprinting a Tri-layered Skin Analogue.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Generation of Human Bioartificial Tissues Using Agarose-Derived Biomaterials.Materials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although it is now possible to use tissue engineering approaches to regenerate the dermis and epidermis of the skin, replicating the cellular framework and functions of the skin's three primary layers-epidermis, dermis, and hypodermis remains challenging. Here, we describe the use of a bioprinting method known as suspended layer additive manufacturing (SLAM) to produce a structure with a gradient of mechanical properties, supporting the growth of various cell types, to create a continuous tri-layered skin substitute that closely mimics human skin. SLAM utilizes fluid gels as a temporary support matrix to facilitate the extrusion bioprinting of soft hydrogel-based bioinks into complex, functional, three-dimensional (3D) tissue structures. The printed structures are initially designed using computer-aided design (CAD) and may be printed using a variety of bioinks that can replicate the three primary skin layers: epidermal, dermal, and hypodermal. To accurately reproduce the cellular framework and functions of human skin, it is crucial to use materials that can duplicate the natural extracellular matrix (ECM) structure. This structure provides structural support and appropriate biochemical cues to the embedded cells. Here we describe a method that uses pectin to mimic ECM polysaccharides, along with collagen, which is a major component of human skin ECM. The resulting structure is supported within an agarose support-bed and ionically cross-linked prior to removal. To accurately replicate the cellular framework of human skin, human epidermal keratinocytes (hEKs), human dermal fibroblasts (HDFs), and adipose-derived stem cells (ADSCs) were integrated into the scaffold. A 21-day culture of the skin construct showed that the cellular components were crucial in remodelling the printed structure into architectures resembling those of healthy skin. Integration of the implant, demonstrated by the mobilization of adipose tissue from the surrounding area into the construct, occurred within 7 days post-ex vivo implantation into a simulated porcine wound.
Indexed as
Identifiers
40208535What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.